Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Medical Imaging
  4. Volume 20, Issue 1
  5. Article
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603
file format pdf download PDF
side by side viewer icon HTML

Abstract

Introduction:

Clear cell hepatocellular carcinoma (HCC) is a rare subtype of HCC. Histologically, clear cell HCC is characterized by the cytoplasmic accumulation of glycogen with a clear cell appearance, constituting > 80% of tumor cells. Radiologically, clear cell HCC demonstrates early enhancement and washout similar to conventional HCC. Occasionally, enhancing capsule and intratumoral fat are accompanied by clear cell HCC.

Case Description:

A 57-year-old male presented to our hospital with right upper quadrant abdominal pain. Ultrasonography, computed tomography, and magnetic resonance imaging revealed a large mass with a well-defined margin in the right hemiliver. The patient underwent a right hemihepatectomy, and the final histopathology revealed clear cell-type HCC.

Conclusion:

Distinguishing clear cell types from other types of HCC solely based on radiological findings is challenging. If hepatic tumors exhibit encapsulated margins, enhancing rims, intratumoral fat, and arterial phase hyperenhancement/washout pattern despite their large size, consideration of clear cell subtypes in the differential diagnosis list will aid patient management, implying better prognosis than not-otherwise-specified HCC.

© 2024 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmim/10.2174/1573405620666230522144730
2023-08-16
2025-04-13

  • From This Site

    /content/journals/cmim/10.2174/1573405620666230522144730
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
The full text of this item is not currently available.

References

  1. TorbensonM.S. NgI.O.L. ParkY.N. RoncalliM. SakamotoM. Hepatocellular carcinomaWHO Classification of tumours editorial board, editor. Digestive system tumours. WHO classification of tumours series.5th ed.Lyon: International Agency for Research on Cancer2019
     [Google Scholar]
  2. KimH. JangM. ParkY.N.J.J.L.C. Histopathological variants of hepatocellular carcinomas: An update according to the 5th Edition of the WHO classification of digestive system tumors. J Liver Cancer 2020201172410.17998/jlc.20.1.17
     [Google Scholar]
  3. FerrellL.D. KakarS. TerraccianoL.M. WeeA. Tumours and tumourlike lesions of the liver.Hubscher SG: MacSween’s Pathology of the LiverBurt AD, Ferrell LD 7th ed.PhiladelphiaPhiladelphia: Elsevier.2018780879
     [Google Scholar]
  4. IrisD.L. RobertD.O. DavidK. ValerieP. MassimoR. PeterS. KayM.W. FatimaC. IanA.C. The 2019 WHO classification of tumours of the digestive system.Histopathology.2019762182188
     [Google Scholar]
  5. LoyL.M. HsienM.L. JinY.C. Variant hepatocellular carcinoma subtypes according to the 2019 who classification: An imaging-focused review.AJR Am J Roentgenol2022219221222310.2214/AJR.21.26982
     [Google Scholar]
  6. ParkB.V. RonC.G. Yu-HuiH. Histology of hepatocellular carcinoma: Association with clinical features, radiological findings, and locoregional therapy outcomes.J Clin Imaging Sci201995210.25259/JCIS_111_2019
     [Google Scholar]
  7. YangS.H. JW. ON. Clinicopathologic study on clear cell hepatocellular carcinoma.Pathol Int1996467503910.1111/j.1440‑1827.1996.tb03645.x
     [Google Scholar]
  8. JiS.-P. LiQ. DongH. Therapy and prognostic features of primary clear cell carcinoma of the liver.World J Gastroenterol2010166764910.3748/wjg.v16.i6.764
     [Google Scholar]
  9. LaiC.L. WuP.C. LamK.C. ToddD. Histologic prognostic indicators in hepatocellular carcinoma.Cancer19794451677168310.1002/1097‑0142(197911)44:5<1677::AID‑CNCR2820440522>3.0.CO;2‑D227575
     [Google Scholar]
  10. LiuJ.H. TsaiH.L. HsuS.M. HuD.H. ChenS.S. Clear cell and non-clear cell hepatocellular carcinoma: A case report and literature review.Kaohsiung J. Med. Sci.2004202788110.1016/S1607‑551X(09)70088‑915481555
     [Google Scholar]
  11. TakahashiA. SaitoH. KannoY. AbeK. YokokawaJ. IrisawaA. KenjoA. SaitoT. GotohM. OhiraH. Case of clear-cell hepatocellular carcinoma that developed in the normal liver of a middle-aged woman.World J. Gastroenterol.200814112913110.3748/wjg.14.12918176975
     [Google Scholar]
  12. SalvucciM. LemoineA. SaffroyR. AzoulayD. LepèreB. GaillardS. BismuthH. ReynèsM. DebuireB. Microsatellite instability in European hepatocellular carcinoma.Oncogene199918118118710.1038/sj.onc.12022799926933
     [Google Scholar]
  13. EmileJ.F. AL. DA. Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinoma.Histopathology20013832253110.1046/j.1365‑2559.2001.01096.x
     [Google Scholar]
  14. LiuZ. WeidongM. HuikaiL. Clinicopathological and prognostic features of primary clear cell carcinoma of the liver.Hepatol Res2008383291910.1111/j.1872‑034X.2007.00264.x
     [Google Scholar]
  15. Yongxin ChenJ.Z.H.K. A Giant Primary Clear Cell Hepatocellular Carcinoma in a Young Woman without Cirrhosis.J. Clin. Exp. Pathol.20155322410.4172/2161‑0681.1000224
     [Google Scholar]
  16. JeonS.-W. MyungL.-K. YoungL.-D. Clear cell hepatocellular carcinoma with spontaneous regression of primary and metastatic lesions.Korean J Intern Med20052032687310.3904/kjim.2005.20.3.268
     [Google Scholar]
  17. OutwaterE.K. BhatiaM. SiegelmanE.S. BurkeM.A. MitchellD.G. Lipid in renal clear cell carcinoma: Detection on opposed-phase gradient-echo MR images.Radiology1997205110310710.1148/radiology.205.1.93149709314970
     [Google Scholar]
  18. YoshimitsuK. HondaH. KuroiwaT. IrieH. TajimaT. JimiM. KuroiwaK. NaitoS. MasudaK. MR detection of cytoplasmic fat in clear cell renal cell carcinoma utilizing chemical shift gradient-echo imaging.J. Magn. Reson. Imaging19999457958510.1002/(SICI)1522‑2586(199904)9:4<579::AID‑JMRI12>3.0.CO;2‑S10232518
     [Google Scholar]
  19. WangH. CT findings of primary clear cell carcinoma of liver: With analysis of 19 cases and review of the literature.Abdom Imaging201439 47364310.1007/s00261‑014‑0104‑2
     [Google Scholar]
  20. WillattJ.M. HussainH.K. AdusumilliS. MarreroJ.A. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: Challenges and controversies.Radiology2008247231133010.1148/radiol.247206133118430871
     [Google Scholar]
  21. JeongY.Y. YimN.Y. KangH.K. Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: Imaging spectrum and pitfalls of cirrhosis-related nodules.AJR Am. J. Roentgenol.200518541024103210.2214/AJR.04.109616177427
     [Google Scholar]
  22. BrancatelliG. FederleM.P. GrazioliL. CarrB.I. Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 U.S. residents.Radiology20022221899410.1148/radiol.222101076711756710
     [Google Scholar]
  23. KutamiR NakashimaY NakashimaO ShiotaK KojiroM Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans.J Hepatol2000332282910.1016/S0168‑8278(00)80369‑4
     [Google Scholar]
  24. LiuQ.-Y. Hai-GangL. MingG. Primary clear cell carcinoma in the liver: CT and MRI findings.World J Gastroenterol20111779465210.3748/wjg.v17.i7.946
     [Google Scholar]
  25. BuchananT.F.Jr HuvosA.G.J.A.J.o.C.P. Clear-cell carcinoma of the liver. A clinicopathologic study of 13 patients.Am J Clin Pathol19746145293910.1093/ajcp/61.4.529
     [Google Scholar]
  26. ChungYE ParkMS ParkYN Hepatocellular carcinoma variants: Radiologic-pathologic correlation.AJR Am J Roentgenol1931W71310.2214/AJR.07.3947
     [Google Scholar]
  27. SakhujaP. PramodKM. RajeshR. Clear cell hepatocellular carcinoma: Back to the basics for diagnosis.J Cancer Res Ther113656201510.4103/0973‑1482.136041
     [Google Scholar]
  28. MonzawaS. OmataK. ShimazuN. YagawaA. HosodaK. ArakiT. Well-differentiated hepatocellular carcinoma: Findings of US, CT, and MR imaging.Abdom. Imaging199924439239710.1007/s00261990052110390564
     [Google Scholar]
  29. GrazioliL. OlivettiL. FugazzolaC. BenettiA. StangaC. DettoriE. GalloC. MatricardiL. GiacobbeA. ChiesaA. The pseudocapsule in hepatocellular carcinoma: Correlation between dynamic MR imaging and pathology.Eur. Radiol.199991626710.1007/s0033000506299933382
     [Google Scholar]
  30. TanY. XiaoE. Rare hepatic malignant tumors: Dynamic CT, MRI, and clinicopathologic features: with analysis of 54 cases and review of the literature.Abdom. Imaging201338351152610.1007/s00261‑012‑9918‑y22669313
     [Google Scholar]
  31. MurakataL.A. IshakK.G. NzeakoU.C. Clear cell carcinoma of the liver: A comparative immunohistochemical study with renal clear cell carcinoma.Mod. Pathol.200013887488110.1038/modpathol.388015610955454
     [Google Scholar]
  32. KimB. LeeJ.H. KimJ.K. KimH.J. KimY.B. LeeD. The capsule appearance of hepatocellular carcinoma in gadoxetic acid-enhanced MR imaging.Medicine20189725e1114210.1097/MD.000000000001114229924016
     [Google Scholar]
  33. AnC. RheeH. HanK. ChoiJ.Y. ParkY.N. ParkM.S. KimM.J. ParkS. Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.Eur. Radiol.20172762610261810.1007/s00330‑016‑4634‑627770230
     [Google Scholar]
  34. IshigamiK. YoshimitsuK. NishiharaY. IrieH. AsayamaY. TajimaT. NishieA. HirakawaM. UshijimaY. OkamotoD. TaketomiA. HondaH. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: Correlation with histopathologic findings.Radiology2009250243544310.1148/radiol.250107170219095782
     [Google Scholar]
  35. Dioguardi BurgioM. PiconeD. CabibboG. MidiriM. LagallaR. BrancatelliG. MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: Comparison of gadoxetic acid and gadobenate dimeglumine.Abdom. Radiol.20164181546155410.1007/s00261‑016‑0726‑727052455
     [Google Scholar]
  36. RimolaJ. FornerA. TremosiniS. ReigM. VilanaR. BianchiL. Rodríguez-LopeC. SoléM. AyusoC. BruixJ. Non-invasive diagnosis of hepatocellular carcinoma ≤2cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI.J. Hepatol.20125661317132310.1016/j.jhep.2012.01.00422314420
     [Google Scholar]
  37. YeX.P. LiL.Q. PengT. XiaoK.Y. SuZ.X. ShangL.M. SuM. XuB.H. [Diagnosis and treatment of primary clear cell carcinoma of the liver].Zhonghua Zhong Liu Za Zhi2010321646620211073
     [Google Scholar]
  38. LaoX.M. ZhangY.Q. JinX. LinX.J. GuoR.P. LiG.H. LiJ.Q. Primary clear cell carcinoma of liver--clinicopathologic features and surgical results of 18 cases.Hepatogastroenterology2006536712813216506391
     [Google Scholar]
  39. AvilaM.A. BerasainC. SangroB. PrietoJ. New therapies for hepatocellular carcinoma.Oncogene200625273866388410.1038/sj.onc.120955016799628
     [Google Scholar]
  40. BruixJ. ShermanM. Management of hepatocellular carcinoma.Hepatology20054251208123610.1002/hep.2093316250051
     [Google Scholar]
  41. LiT. FanJ. QinLun-Xiu Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver.Ann Surg Oncol201118719556310.1245/s10434‑010‑1540‑z
     [Google Scholar]
  42. ParfittJ.R. MarottaP. AlGhamdiM. WallW. KhakharA. SuskinN.G. QuanD. McAllisterV. GhentC. LevstikM. McLeanC. ChakrabartiS. GarciaB. DrimanD.K. Recurrent hepatocellular carcinoma after transplantation: Use of a pathological score on explanted livers to predict recurrence.Liver Transpl.200713454355110.1002/lt.2107817394152
     [Google Scholar]
  43. UenoS. TanabeG. YoshidaA. YoshidomeS. TakaoS. AikouT. Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis.Cancer199986224825410.1002/(SICI)1097‑0142(19990715)86:2<248::AID‑CNCR8>3.0.CO;2‑110421260
     [Google Scholar]
  44. PandeyD. LeeK.H. WaiC.T. WagholikarG. TanK.C. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection.Ann. Surg. Oncol.200714102817282310.1245/s10434‑007‑9518‑117690940
     [Google Scholar]
  45. WeiX PengleiG WenjunL Edmondson grade predicts survival of patients with primary clear cell carcinoma of liver after curative resection: A retrospective study with long-term follow-up.Asia Pac J Clin Oncol2017135e312e32010.1111/ajco.12494
     [Google Scholar]
  46. McDermottW.V. CadyB. GeorgiB. SteeleG.Jr KhettryU. Primary cancer of the liver. Evaluation, treatment, and prognosis.Arch. Surg.1989124555255410.1001/archsurg.1989.014100500420072540731
     [Google Scholar]
  47. ShahS GuptaS ShetT Metastatic clear cell variant of hepatocellular carcinoma with an occult hepatic primary.Hepatobiliary Pancreat Dis Int2005423067
     [Google Scholar]
  48. Chin’ombeN. ChavhundukaE. MatariraH.T. Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe.Infect. Agent. Cancer2009411510.1186/1750‑9378‑4‑1519814789
     [Google Scholar]
  49. BarazaniY. HiattJ.R. TongM.J. BusuttilR.W. Chronic viral hepatitis and hepatocellular carcinoma.World J. Surg.20073161245125010.1007/s00268‑007‑9041‑317440771
     [Google Scholar]
  50. ButD.Y.K. LaiC.L. YuenM.F. Natural history of hepatitis-related hepatocellular carcinoma.World J. Gastroenterol.200814111652165610.3748/wjg.14.165218350595
     [Google Scholar]
/content/journals/cmim/10.2174/1573405620666230522144730
Loading
Huge Primary Clear Cell Hepatocellular Carcinoma: A Case Report and Review of Radiologic Findings
Curr. Med. Imaging 20, e220523217193 (2024); https://doi.org/10.2174/1573405620666230522144730
/content/journals/cmim/10.2174/1573405620666230522144730
/content/journals/cmim/10.2174/1573405620666230522144730
Loading

Data & Media loading...


  • Article Type:     Case Report
Keyword(s): Carcinoma; Clear cell; Computed tomography; Hepatocellular; Liver; Magnetic resonance imaging

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test